Case Study: a global pharmaceutical company improves quality-of-life data and suicidality monitoring with ObvioHealth

Global Pharmaceutical Company - Customer Case Study

A global pharmaceutical company sought to understand the impact of a dissociative anesthetic on quality of life for patients with treatment-resistant depression. Their challenge was to gather high-quality data while meticulously monitoring patient safety, particularly for suicidality, all within a protocol designed to significantly reduce patient burden from site visits. They partnered with ObvioHealth for a solution.

ObvioHealth implemented a hybrid study using a combination of ePRO and eClinRO for a complete picture of quality of life. Their platform featured immediate alerts to site teams if a participant reported suicidal ideations. After extensive site training across Australia and New Zealand, ObvioHealth delivered the evidence needed for the client to submit a bid for approval to Australia’s Pharmaceutical Benefits Advisory Committee (PBAC).